SEARCH:   Advanced

Blood, 15 May 2005, Vol. 105, No. 10, pp. 3768-3785. Prepublished online as a Blood First Edition Paper on February 3, 2005; DOI 10.1182/blood-2004-09-3502. This Article Full Text (PDF) All Versions of this Article: 2004-09-3502v1 105/10/3768    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Willemze, R. Articles by Meijer, C. J Search for Related Content PubMed PubMed Citation Articles by Willemze, R. Articles by Meijer, C. J Related Collections Related Article in Blood Online Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted September 10, 2004 Accepted January 11, 2005 WHO-EORTC classification for cutaneous lymphomas Rein Willemze*, Elaine S Jaffe, Gunter Burg, Lorenzo Cerroni, Emilio Berti, Steven H Swerdlow, Elisabeth Ralfkiaer, Sergio Chimenti, Jose L Diaz-Perez, Lyn M Duncan, Florent Grange, Nancy L Harris, Werner Kempf, Helmut Kerl, Michael Kurrer, Robert Knobler, Nicola Pimpinelli, Christian Sander, Marco Santucci, Wolfram Sterry, Maarten H Vermeer, Janine Wechsler, Sean Whittaker, and Chris J Meijer Dept. of Dermatology, Leiden University Medical Center, Leiden, The Netherlands Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Dept. of Dermatology, University Hospital Zurich, Zurich, Switzerland Dept. of Dermatology, University of Graz, Graz, Austria Dept. of Dermatology, University of Milan-Biococca and Ospedale Magiore, IRCCS, Milan, Italy Dept. of Pathology, Division of Hematopathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Dept. of Pathology, University of Copenhagen, Copenhagen, Denmark Dept. of Dermatology, University of Rome, Rome, Italy Dept. of Dermatology, Cruces Hospital, Bilbao, Spain Dept. of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA Dept. of Dermatology, Hopital Pasteur, Colmar, France Dept. of Pathology, University Hospital Zurich, Zurich, Switzerland Dept. of Dermatology, University of Vienna, Vienna, Austria Dept. of Dermatological Sciences, University of Florence, Florence, Italy Dept. of Dermatology, Allgemeines Krankenhaus St. Georg, Hamburg, Germany Dept. of Human Pathology and Oncology, University of Florence, Florence, Italy Dept. of Dermatology, Charite, Humboldt University, Berlin, Germany Dept. of Pathology, Hopital Henri Mondor, Creteil, France Skin Tumour Unit, St. John's Institute of Dermatology, St. Thomas' Hospital, London, England Dept. of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands * Corresponding author; email: rein.willemze{at}planet.nl. Primary cutaneous lymphomas are currently classified by the EORTC classification or the WHO classification, but both systems have shortcomings. In particular, differences in the classification of cutaneous T-cell lymphomas other than mycosis fungoides, Sezary syndrome and the group of primary cutaneous CD30-positive lymphoproliferative disorders and the classification and terminology of different types of cutaneous B-cell lymphomas have resulted in considerable debate and confusion. During recent consensus meetings representatives of both systems reached agreement on a new classification, which is now called the WHO-EORTC classification. In this paper we describe the characteristic features of the different primary cutaneous lymphomas and other hematologic neoplasms frequently presenting in the skin, and discuss differences with the previous classification schemes . In addition, the relative frequency and survival data of 1905 patients with primary cutaneous lymphomas derived from Dutch and Austrian registries for primary cutaneous lymphomas are presented to illustrate the clinical significance of this new classification. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Article in Blood Online: Latest lymphoma classification is skin deep Marshall E. Kadin Blood 2005 105: 3759. [Full Text] [PDF] This article has been cited by other articles: H. M. Prince, S. Whittaker, and R. T. Hoppe How I treat mycosis fungoides and Sezary syndrome Blood, November 12, 2009; 114(20): 4337 - 4353. [Abstract] [Full Text] [PDF] C. L. Salisbury, S. D. Budnick, and S. Li T-Cell Receptor Gene Rearrangement and CD30 Immunoreactivity in Traumatic Ulcerative Granuloma With Stromal Eosinophilia of the Oral Cavity Am J Clin Pathol, November 1, 2009; 132(5): 722 - 727. [Abstract] [Full Text] [PDF] E. Caprini, C. Cristofoletti, D. Arcelli, P. Fadda, M. H. Citterich, F. Sampogna, A. Magrelli, F. Censi, P. Torreri, M. Frontani, et al. Identification of Key Regions and Genes Important in the Pathogenesis of Sezary Syndrome by Combining Genomic and Expression Microarrays Cancer Res., November 1, 2009; 69(21): 8438 - 8446. [Abstract] [Full Text] [PDF] E. L. Trimble, J. S. Abrams, R. M. Meyer, F. Calvo, E. Cazap, J. Deye, E. Eisenhauer, T. J. Fitzgerald, D. Lacombe, M. Parmar, et al. Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials J. Clin. Oncol., October 20, 2009; 27(30): 5109 - 5114. [Abstract] [Full Text] [PDF] Asymptomatic Red Plaque on the Leg of a 7-Year-Old Girl--Diagnosis Arch Dermatol, October 1, 2009; 145(10): 1183 - 1188. [Full Text] [PDF] F. N. Moura, L. Thomas, B. Balme, and S. Dalle Dermoscopy of Lymphomatoid Papulosis Arch Dermatol, August 1, 2009; 145(8): 966 - 966. [Full Text] [PDF] L. Stimson, V. Wood, O. Khan, S. Fotheringham, and N. B. La Thangue HDAC inhibitor-based therapies and haematological malignancy Ann. Onc., August 1, 2009; 20(8): 1293 - 1302. [Abstract] [Full Text] [PDF] R. H. Weenig, N. I. Comfere, L. E. Gibson, J. Alonso-Llamazares, M. D. P. Davis, M. R. Pittelkow, and R. A. el-Azhary Fatal Cytotoxic Cutaneous Lymphoma Presenting as Ulcerative Psoriasis Arch Dermatol, July 1, 2009; 145(7): 801 - 808. [Abstract] [Full Text] [PDF] J. Guitart and G. S. Wood On the Trail of a New Killer Arch Dermatol, July 1, 2009; 145(7): 811 - 813. [Full Text] [PDF] W. Kempf "Cutaneous T-Cell Lymphoma": Cutaneous TNMania in Cutaneous Lymphomas--Reply Arch Dermatol, July 1, 2009; 145(7): 843 - 843. [Full Text] [PDF] S. M. Worobec Efalizumab and Progression of Undiagnosed Follicular Mycosis Fungoides--Reply Arch Dermatol, July 1, 2009; 145(7): 844 - 844. [Full Text] [PDF] T. Krejsgaard, C. S. Vetter-Kauczok, A. Woetmann, H. Kneitz, K. W. Eriksen, P. Lovato, Q. Zhang, M. A. Wasik, C. Geisler, E. Ralfkiaer, et al. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma Blood, June 4, 2009; 113(23): 5896 - 5904. [Abstract] [Full Text] [PDF] I. W. Mattoch, R. Fulton, Y. Kim, R. Hoppe, R. A. Warnke, and U. N. Sundram Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells Am J Clin Pathol, June 1, 2009; 131(6): 810 - 819. [Abstract] [Full Text] [PDF] M. Roullet, S. M.F. Gheith, J. Mauger, J. M. Junkins-Hopkins, and J. K. Choi Percentage of {gamma}{delta} T Cells in Panniculitis by Paraffin Immunohistochemical Analysis Am J Clin Pathol, June 1, 2009; 131(6): 820 - 826. [Abstract] [Full Text] [PDF] D. K. Woo, C. R. Jones, M. N. Vanoli-Storz, S. Kohler, S. Reddy, R. Advani, R. T. Hoppe, and Y. H. Kim Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Characterization of Clinical Subset With Worse Outcome Arch Dermatol, June 1, 2009; 145(6): 667 - 674. [Abstract] [Full Text] [PDF] B. Poligone, L. D. Wilson, A. Subtil, and P. Heald Primary Cutaneous T-Cell Lymphoma Localized to the Lower Leg: A Distinct, Locally Aggressive Cutaneous T-Cell Lymphoma Arch Dermatol, June 1, 2009; 145(6): 677 - 682. [Abstract] [Full Text] [PDF] F. Grange and F. Antonicelli Cutaneous Lymphomas: What Can We Learn From Location? Arch Dermatol, June 1, 2009; 145(6): 710 - 712. [Full Text] [PDF] P. T. Bradford, S. S. Devesa, W. F. Anderson, and J. R. Toro Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases Blood, May 21, 2009; 113(21): 5064 - 5073. [Abstract] [Full Text] [PDF] C.-D. Klemke, D. Brenner, E.-M. Weiss, M. Schmidt, M. Leverkus, K. Gulow, and P. H. Krammer Lack of T-Cell Receptor-Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death Cancer Res., May 15, 2009; 69(10): 4175 - 4183. [Abstract] [Full Text] [PDF] E. Kennah, A. Ringrose, L. L. Zhou, S. Esmailzadeh, H. Qian, M.-w. Su, Y. Zhou, and X. Jiang Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells Blood, May 7, 2009; 113(19): 4646 - 4655. [Abstract] [Full Text] [PDF] R. Willemze, M. Dreyling, and On behalf of the ESMO Guidelines Working Group Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann. Onc., May 1, 2009; 20(suppl_4): iv115 - iv118. [Full Text] [PDF] J. Chen, W. Fiskus, K. Eaton, P. Fernandez, Y. Wang, R. Rao, P. Lee, R. Joshi, Y. Yang, R. Kolhe, et al. Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism Blood, April 23, 2009; 113(17): 4038 - 4048. [Abstract] [Full Text] [PDF] S. Mathas, S. Kreher, K. J. Meaburn, K. Johrens, B. Lamprecht, C. Assaf, W. Sterry, M. E. Kadin, M. Daibata, S. Joos, et al. Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma PNAS, April 7, 2009; 106(14): 5831 - 5836. [Abstract] [Full Text] [PDF] M. G. Cornejo, M. G. Kharas, M. B. Werneck, S. L. Bras, S. A. Moore, B. Ball, M. Beylot-Barry, S. J. Rodig, J. C. Aster, B. H. Lee, et al. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models Blood, March 19, 2009; 113(12): 2746 - 2754. [Abstract] [Full Text] [PDF] M. K. Kiessling, C. D. Klemke, M. M. Kaminski, I. E. Galani, P. H. Krammer, and K. Gulow Inhibition of Constitutively Activated Nuclear Factor-{kappa}B Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma Cancer Res., March 15, 2009; 69(6): 2365 - 2374. [Abstract] [Full Text] [PDF] F. Grange, E. Maubec, M. Bagot, M. Beylot-Barry, P. Joly, S. Dalle, E. Delaporte, O. Dereure, H. Bachelez, B. Vergier, et al. Treatment of Cutaneous B-Cell Lymphoma, Leg Type, With Age-Adapted Combinations of Chemotherapies and Rituximab Arch Dermatol, March 1, 2009; 145(3): 329 - 330. [Full Text] [PDF] S. R. Lessin Alibert Lymphoma: Renaming Mycosis Fungoides Arch Dermatol, February 1, 2009; 145(2): 209 - 210. [Full Text] [PDF] J. Valencak, F. Weihsengruber, K. Rappersberger, F. Trautinger, A. Chott, B. Streubel, L. Muellauer, M. Der-Petrossian, C. Jonak, M. Binder, et al. Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients Ann. Onc., February 1, 2009; 20(2): 326 - 330. [Abstract] [Full Text] [PDF] R. van Doorn, M. S. van Kester, R. Dijkman, M. H. Vermeer, A. A. Mulder, K. Szuhai, J. Knijnenburg, J. M. Boer, R. Willemze, and C. P. Tensen Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome Blood, January 1, 2009; 113(1): 127 - 136. [Abstract] [Full Text] [PDF] W. Kempf, S. Ostheeren-Michaelis, M. Paulli, M. Lucioni, J. Wechsler, H. Audring, C. Assaf, T. Rudiger, R. Willemze, C. J. L. M. Meijer, et al. Granulomatous Mycosis Fungoides and Granulomatous Slack Skin: A Multicenter Study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer (EORTC) Arch Dermatol, December 1, 2008; 144(12): 1609 - 1617. [Abstract] [Full Text] [PDF] E. S. Jaffe, N. L. Harris, H. Stein, and P. G. Isaacson Classification of lymphoid neoplasms: the microscope as a tool for disease discovery Blood, December 1, 2008; 112(12): 4384 - 4399. [Abstract] [Full Text] [PDF] M. Neta, D. Naigamwalla, and D. Bienzle Perforin expression in feline epitheliotropic cutaneous lymphoma J Vet Diagn Invest, November 1, 2008; 20(6): 831 - 835. [Abstract] [Full Text] [PDF] S. O. Arulogun, H. M. Prince, J. Ng, S. Lade, G. F. Ryan, O. Blewitt, and C. McCormack Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation Blood, October 15, 2008; 112(8): 3082 - 3087. [Abstract] [Full Text] [PDF] F. van Maldegem, R. van Dijk, T. A. M. Wormhoudt, P. M. Kluin, R. Willemze, L. Cerroni, C. J. M. van Noesel, and R. J. Bende The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment Blood, October 15, 2008; 112(8): 3355 - 3361. [Abstract] [Full Text] [PDF] M. C. Picchio, E. Scala, D. Pomponi, E. Caprini, M. Frontani, I. Angelucci, A. Mangoni, C. Lazzeri, M. Perez, D. Remotti, et al. CXCL13 Is Highly Produced by Sezary Cells and Enhances Their Migratory Ability via a Synergistic Mechanism Involving CCL19 and CCL21 Chemokines Cancer Res., September 1, 2008; 68(17): 7137 - 7146. [Abstract] [Full Text] [PDF] D. Shafer, H. Wu, T. Al-Saleem, K. Reddy, H. Borghaei, S. Lessin, and M. Smith Cutaneous Precursor B-Cell Lymphoblastic Lymphoma in 2 Adult Patients: Clinicopathologic and Molecular Cytogenetic Studies With a Review of the Literature Arch Dermatol, September 1, 2008; 144(9): 1155 - 1162. [Abstract] [Full Text] [PDF] N. J. Senff, E. M. Noordijk, Y. H. Kim, M. Bagot, E. Berti, L. Cerroni, R. Dummer, M. Duvic, R. T. Hoppe, N. Pimpinelli, et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas Blood, September 1, 2008; 112(5): 1600 - 1609. [Abstract] [Full Text] [PDF] M. Kasprzycka, Q. Zhang, A. Witkiewicz, M. Marzec, M. Potoczek, X. Liu, H. Y. Wang, M. Milone, S. Basu, J. Mauger, et al. {gamma}c-Signaling Cytokines Induce a Regulatory T Cell Phenotype in Malignant CD4+ T Lymphocytes J. Immunol., August 15, 2008; 181(4): 2506 - 2512. [Abstract] [Full Text] [PDF] C. E. Introcaso, E. J. Kim, J. Gardner, J. M. Junkins-Hopkins, C. C. Vittorio, and A. H. Rook CD8+ Epidermotropic Cytotoxic T-Cell Lymphoma With Peripheral Blood and Central Nervous System Involvement Arch Dermatol, August 1, 2008; 144(8): 1027 - 1029. [Abstract] [Full Text] [PDF] L. Ellis, Y. Pan, G. K. Smyth, D. J. George, C. McCormack, R. Williams-Truax, M. Mita, J. Beck, H. Burris, G. Ryan, et al. Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma Clin. Cancer Res., July 15, 2008; 14(14): 4500 - 4510. [Abstract] [Full Text] [PDF] A. Garcia-Herrera, L. Colomo, M. Camos, J. Carreras, O. Balague, A. Martinez, A. Lopez-Guillermo, T. Estrach, and E. Campo Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome J. Clin. Oncol., July 10, 2008; 26(20): 3364 - 3371. [Abstract] [Full Text] [PDF] P. Gerami, S. Rosen, T. Kuzel, S. L. Boone, and J. Guitart Folliculotropic Mycosis Fungoides: An Aggressive Variant of Cutaneous T-Cell Lymphoma Arch Dermatol, June 1, 2008; 144(6): 738 - 746. [Abstract] [Full Text] [PDF] W. Sterry and L. Heinzerling Clinical Research in Cutaneous T-Cell Lymphoma Moving Forward Arch Dermatol, June 1, 2008; 144(6): 786 - 787. [Full Text] [PDF] J Csomor, A Bognar, S Benedek, J Sinko, S Fekete, L Krenacs, A Matolcsy, and L Reiniger Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman J. Clin. Pathol., June 1, 2008; 61(6): 770 - 772. [Abstract] [Full Text] [PDF] M. H. Vermeer, R. van Doorn, R. Dijkman, X. Mao, S. Whittaker, P. C. van Voorst Vader, M.-J. P. Gerritsen, M.-L. Geerts, S. Gellrich, O. Soderberg, et al. Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome Cancer Res., April 15, 2008; 68(8): 2689 - 2698. [Abstract] [Full Text] [PDF] T. Marafioti, J. C. Paterson, E. Ballabio, K. K. Reichard, S. Tedoldi, K. Hollowood, M. Dictor, M.-L. Hansmann, S. A. Pileri, M. J. Dyer, et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells Blood, April 1, 2008; 111(7): 3778 - 3792. [Abstract] [Full Text] [PDF] J. B. Yu, R. C. Blitzblau, R. H. Decker, D. M. Housman, and L. D. Wilson Analysis of Primary CD30+ Cutaneous Lymphoproliferative Disease and Survival From the Surveillance, Epidemiology, and End Results Database J. Clin. Oncol., March 20, 2008; 26(9): 1483 - 1488. [Abstract] [Full Text] [PDF] M. Marzec, K. Halasa, M. Kasprzycka, M. Wysocka, X. Liu, J. W. Tobias, D. Baldwin, Q. Zhang, N. Odum, A. H. Rook, et al. Differential Effects of Interleukin-2 and Interleukin-15 versus Interleukin-21 on CD4+ Cutaneous T-Cell Lymphoma Cells Cancer Res., February 15, 2008; 68(4): 1083 - 1091. [Abstract] [Full Text] [PDF] M. Marzec, X. Liu, M. Kasprzycka, A. Witkiewicz, P. N. Raghunath, M. El-Salem, E. Robertson, N. Odum, and M. A. Wasik IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes Blood, February 15, 2008; 111(4): 2181 - 2189. [Abstract] [Full Text] [PDF] M Lira, A A Schenka, L A Magna, A C Cotta, M L Cintra, E M de Souza, P Brousset, and J Vassallo Diagnostic value of combining immunostaining for CD3 and nuclear morphometry in mycosis fungoides J. Clin. Pathol., February 1, 2008; 61(2): 209 - 212. [Abstract] [Full Text] [PDF] R. Willemze, P. M. Jansen, L. Cerroni, E. Berti, M. Santucci, C. Assaf, M. R. Canninga-van Dijk, A. Carlotti, M.-L. Geerts, S. Hahtola, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases Blood, January 15, 2008; 111(2): 838 - 845. [Abstract] [Full Text] [PDF] K. J. Savage Prognosis and Primary Therapy in Peripheral T-Cell Lymphomas Hematology, January 1, 2008; 2008(1): 280 - 288. [Abstract] [Full Text] [PDF] M. A. Habra, E. J. Weaver, and P. V. Prewitt III Primary Cutaneous Large B-Cell Lymphoma of the Leg and Acute Hypercalcemia J. Clin. Oncol., December 20, 2007; 25(36): 5825 - 5826. [Full Text] [PDF] V. Liu, C. S. Cutler, and A. Z. Young Case 38-2007 -- A 44-Year-Old Woman with Generalized, Painful, Ulcerated Skin Lesions N. Engl. J. Med., December 13, 2007; 357(24): 2496 - 2505. [Full Text] [PDF] N. J. Senff, J. J. Hoefnagel, K. J. Neelis, M. H. Vermeer, E. M. Noordijk, R. Willemze, and for the Dutch Cutaneous Lymphoma Group Results of Radiotherapy in 153 Primary Cutaneous B-Cell Lymphomas Classified According to the WHO-EORTC Classification Arch Dermatol, December 1, 2007; 143(12): 1520 - 1526. [Abstract] [Full Text] [PDF] J. Shin, S. Monti, D. J. Aires, M. Duvic, T. Golub, D. A. Jones, and T. S. Kupper Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome Blood, October 15, 2007; 110(8): 3015 - 3027. [Abstract] [Full Text] [PDF] E. M. Buda-Okreglak, M. J. Walden, and M. D. Brissette Perineural CNS Invasion in Primary Cutaneous Follicular Center Lymphoma J. Clin. Oncol., October 10, 2007; 25(29): 4684 - 4686. [Full Text] [PDF] P. L. Zinzani, G. Musuraca, M. Tani, V. Stefoni, E. Marchi, M. Fina, C. Pellegrini, L. Alinari, E. Derenzini, A. de Vivo, et al. Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma J. Clin. Oncol., September 20, 2007; 25(27): 4293 - 4297. [Abstract] [Full Text] [PDF] D. Winter, J. Moser, E. Kriehuber, C. Wiesner, R. Knobler, F. Trautinger, P. Bombosi, G. Stingl, P. Petzelbauer, A. Rot, et al. Down-Modulation of CXCR3 Surface Expression and Function in CD8+ T Cells from Cutaneous T Cell Lymphoma Patients J. Immunol., September 15, 2007; 179(6): 4272 - 4282. [Abstract] [Full Text] [PDF] D. L. Longo Watch out, MF! Blood, September 15, 2007; 110(6): 1708 - 1709. [Full Text] [PDF] E. Olsen, E. Vonderheid, N. Pimpinelli, R. Willemze, Y. Kim, R. Knobler, H. Zackheim, M. Duvic, T. Estrach, S. Lamberg, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) Blood, September 15, 2007; 110(6): 1713 - 1722. [Abstract] [Full Text] [PDF] S. C.-S. Hu, K.-B. Tsai, G.-S. Chen, and P.-H. Chen Infantile CD4+/CD56+ hematodermic neoplasm Haematologica, September 1, 2007; 92(9): e91 - e93. [Full Text] [PDF] E. Callet-Bauchu, G. Salles, S. Gazzo, S. Dalle, F. Berger, and S. Hayette Identification of a novel e8/a4 BCR/ABL fusion transcript in a case of a transformed Sezary syndrome Haematologica, September 1, 2007; 92(9): 1277 - 1278. [Abstract] [Full Text] [PDF] F. Grange, M. Beylot-Barry, P. Courville, E. Maubec, M. Bagot, B. Vergier, P. Souteyrand, L. Machet, S. Dalac, E. Esteve, et al. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases Arch Dermatol, September 1, 2007; 143(9): 1144 - 1150. [Abstract] [Full Text] [PDF] C. Assaf, S. Gellrich, S. Whittaker, A. Robson, L. Cerroni, C. Massone, H. Kerl, C. Rose, A. Chott, S. Chimenti, et al. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer J. Clin. Pathol., September 1, 2007; 60(9): 981 - 989. [Abstract] [Full Text] [PDF] E. A. Olsen, Y. H. Kim, T. M. Kuzel, T. R. Pacheco, F. M. Foss, S. Parker, S. R. Frankel, C. Chen, J. L. Ricker, J. M. Arduino, et al. Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma J. Clin. Oncol., July 20, 2007; 25(21): 3109 - 3115. [Abstract] [Full Text] [PDF] Y. H. Kim, R. Willemze, N. Pimpinelli, S. Whittaker, E. A. Olsen, A. Ranki, R. Dummer, R. T. Hoppe, and for the ISCL and the EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC) Blood, July 15, 2007; 110(2): 479 - 484. [Abstract] [Full Text] [PDF] D. Sanchez-Cano, J. Callejas-Rubio, A. Vilanova-Mateu, M. Gomez-Morales, and N. Ortego-Centeno Intravascular lymphoma in a patient with systemic lupus erythematosus: a case report Lupus, July 1, 2007; 16(7): 525 - 528. [Abstract] [PDF] S. R. Lessin Cutaneous T-Cell Lymphoma Epidemiology: Patients Providing the Power Arch Dermatol, July 1, 2007; 143(7): 916 - 918. [Full Text] [PDF] J. Guitart and C. Magro Cutaneous T-Cell Lymphoid Dyscrasia: A Unifying Term for Idiopathic Chronic Dermatoses With Persistent T-Cell Clones Arch Dermatol, July 1, 2007; 143(7): 921 - 932. [Abstract] [Full Text] [PDF] M. G. Bernengo, P. Quaglino, A. Comessatti, M. Ortoncelli, M. Novelli, F. Lisa, and M. T. Fierro Low-dose intermittent alemtuzumab in the treatment of Sezary syndrome: clinical and immunologic findings in 14 patients Haematologica, June 1, 2007; 92(6): 784 - 794. [Abstract] [Full Text] [PDF] P. Garrido, F. Ruiz-Cabello, P. Barcena, Y. Sandberg, J. Canton, M. Lima, A. Balanzategui, M. Gonzalez, M. A. Lopez-Nevot, A. W. Langerak, et al. Monoclonal TCR-V 13.1+/CD4+/NKa+/CD8 /+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin Blood, June 1, 2007; 109(11): 4890 - 4898. [Abstract] [Full Text] [PDF] Y. H. Kim, M. Duvic, E. Obitz, R. Gniadecki, L. Iversen, A. Osterborg, S. Whittaker, T. M. Illidge, T. Schwarz, R. Kaufmann, et al. Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma Blood, June 1, 2007; 109(11): 4655 - 4662. [Abstract] [Full Text] [PDF] S. Pulini, S. Rupoli, G. Goteri, N. Pimpinelli, R. Alterini, A. Tassetti, A. R. Scortechini, M. Offidani, S. Mulattieri, A. Stronati, et al. Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas Haematologica, May 1, 2007; 92(5): 686 - 689. [Abstract] [Full Text] [PDF] N. J. Senff, J. J. Hoefnagel, P. M. Jansen, M. H. Vermeer, J. van Baarlen, W. A. Blokx, M. R. Canninga-van Dijk, M.-L. Geerts, K. M. Hebeda, P. M. Kluin, et al. Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO-EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers J. Clin. Oncol., April 20, 2007; 25(12): 1581 - 1587. [Abstract] [Full Text] [PDF] A. Woetmann, P. Lovato, K. W. Eriksen, T. Krejsgaard, T. Labuda, Q. Zhang, A.-M. Mathiesen, C. Geisler, A. Svejgaard, M. A. Wasik, et al. Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins Blood, April 15, 2007; 109(8): 3325 - 3332. [Abstract] [Full Text] [PDF] C. M Bacon, M.-Q. Du, and A. Dogan Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists J. Clin. Pathol., April 1, 2007; 60(4): 361 - 372. [Abstract] [Full Text] [PDF] A Nodule on a Boy's Back--Diagnosis Arch Dermatol, March 1, 2007; 143(3): 417 - 422. [Full Text] [PDF] Persistent Violaceous Papules on the Ears--Diagnosis Arch Dermatol, March 1, 2007; 143(3): 417 - 422. [Full Text] [PDF] R. Dijkman, R. van Doorn, K. Szuhai, R. Willemze, M. H. Vermeer, and C. P. Tensen Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities Blood, February 15, 2007; 109(4): 1720 - 1727. [Abstract] [Full Text] [PDF] G. A. Salles Clinical Features, Prognosis and Treatment of Follicular Lymphoma Hematology, January 1, 2007; 2007(1): 216 - 225. [Abstract] [Full Text] [PDF] M. Duvic, R. Talpur, X. Ni, C. Zhang, P. Hazarika, C. Kelly, J. H. Chiao, J. F. Reilly, J. L. Ricker, V. M. Richon, et al. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL) Blood, January 1, 2007; 109(1): 31 - 39. [Abstract] [Full Text] [PDF] R. Bergman, Z. Khamaysi, D. Sahar, and Y. Ben-Arieh Cutaneous Lymphoid Hyperplasia Presenting as a Solitary Facial Nodule: Clinical, Histopathological, Immunophenotypical, and Molecular Studies Arch Dermatol, December 1, 2006; 142(12): 1561 - 1566. [Abstract] [Full Text] [PDF] D Errante, D Bernardi, A Bianco, S De Nardi, and L Salvagno Rituximab-related urticarial reaction in a patient treated for primary cutaneous B-cell lymphoma Ann. Onc., November 1, 2006; 17(11): 1720 - 1721. [Full Text] [PDF] M. Bouzani, T. Karmiris, D. Rontogianni, S. Delimpassi, J. Apostolidis, M. Mpakiri, and E. Nikiforakis Disseminated Intravascular B-Cell Lymphoma: Clinicopathological Features and Outcome of Three Cases Treated with Anthracycline-Based Immunochemotherapy Oncologist, September 1, 2006; 11(8): 923 - 928. [Abstract] [Full Text] [PDF] R. Gruber, N. T. Sepp, P. O. Fritsch, and M. Schmuth Prognosis of Lymphomatoid Papulosis Oncologist, September 1, 2006; 11(8): 955 - 957. [Full Text] [PDF] J. R. Brown In Reply Oncologist, September 1, 2006; 11(8): 957 - 957. [Full Text] [PDF] P. L. Zinzani, P. Quaglino, N. Pimpinelli, E. Berti, G. Baliva, S. Rupoli, M. Martelli, M. Alaibac, G. Borroni, S. Chimenti, et al. In Reply J. Clin. Oncol., August 20, 2006; 24(24): 4041a - 4042. [Full Text] [PDF] S. Hahtola, S. Tuomela, L. Elo, T. Hakkinen, L. Karenko, B. Nedoszytko, H. Heikkila, U. Saarialho-Kere, J. Roszkiewicz, T. Aittokallio, et al. Th1 Response and Cytotoxicity Genes Are Down-Regulated in Cutaneous T-Cell Lymphoma. Clin. Cancer Res., August 15, 2006; 12(16): 4812 - 4821. [Abstract] [Full Text] [PDF] L Cerroni Lymphoproliferative lesions of the skin. J. Clin. Pathol., August 1, 2006; 59(8): 813 - 826. [Abstract] [Full Text] [PDF] E. Jacobsen Anaplastic Large-Cell Lymphoma, T-/Null-Cell Type Oncologist, July 1, 2006; 11(7): 831 - 840. [Abstract] [Full Text] [PDF] Reviews of Note Journal Watch Dermatology, June 27, 2006; 2006(627): 9 - 9. [Full Text] R. Dijkman, C. P. Tensen, M. Buettner, G. Niedobitek, R. Willemze, and M. H. Vermeer Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID Blood, June 15, 2006; 107(12): 4926 - 4929. [Abstract] [Full Text] [PDF] Y. Fujita, R. Abe, M. Sasaki, A. Honda, M. Furuichi, Y. Asano, O. Norisugi, T. Shimizu, and H. Shimizu Presence of Circulating CCR10+ T cells and Elevated Serum CTACK/CCL27 in the Early Stage of Mycosis Fungoides. Clin. Cancer Res., May 1, 2006; 12(9): 2670 - 2675. [Abstract] [Full Text] [PDF] E. Zambrano, O. Mejia-Mejia, C. Bifulco, J. Shin, and M. Reyes-Mugica Extranodal Marginal Zone B-Cell Lymphoma/Maltoma of the Lip in a Child: Case Report and Review of Cutaneous Lymphoid Proliferations in Childhood International Journal of Surgical Pathology, April 1, 2006; 14(2): 163 - 169. [Abstract] [PDF] P. L. Zinzani, P. Quaglino, N. Pimpinelli, E. Berti, G. Baliva, S. Rupoli, M. Martelli, M. Alaibac, G. Borroni, S. Chimenti, et al. Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas J. Clin. Oncol., March 20, 2006; 24(9): 1376 - 1382. [Abstract] [Full Text] [PDF]

	Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020